# Open-label Study Using 50 Mg Liquid Etanercept Subcutaneous Injection in the Thigh to Compare an Auto-injector Device and a Manual Injection in Healthy Subjects

> **NCT02588534** · PHASE1 · COMPLETED · sponsor: **Amgen** · enrollment: 36 (actual)

## Conditions studied

- Healthy Men and Women

## Interventions

- **DEVICE:** etanercept (ENBREL®) via auto-injector device
- **OTHER:** Etanercept (ENBREL®) via Manual injection

## Key facts

- **NCT ID:** NCT02588534
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** 2004-10
- **Final completion:** 2004-10
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2015-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02588534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02588534, "Open-label Study Using 50 Mg Liquid Etanercept Subcutaneous Injection in the Thigh to Compare an Auto-injector Device and a Manual Injection in Healthy Subjects". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02588534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*